MedPage Today -- The ongoing controversy over drug industry influence in continuing medical education may be at the tipping point: Pharmaceutical industry employees will not be allowed to make CME presentations later this year at one of the largest medical meetings in the world -- the American Heart Association’s annual Scientific Sessions.
